Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Developmental Medicine and Child Neurology|July 1, 2009
Neurological manifestations of the Mendelian-inherited autoinflammatory syndromesGina A Montealegre Sanchez, Philip J Hashkes
Journal of Molecular Medicine (Berlin, Germany)|September 29, 2016
Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic LupusHanna Kim, Gina A Montealegre Sanchez, Raphaela Goldbach-Mansky
Rheumatic Diseases Clinics of North America|November 5, 2013
Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulationGina A Montealegre Sanchez, Adriana Almeida de Jesus, Raphaela Goldbach-Mansky
Journal of the American Academy of Dermatology|September 12, 2018
Recurrent fevers, progressive lipodystrophy, and annular plaques in a childMichael A Cardis, Gina A Montealegre Sanchez, Raphaela Goldbach-Mansky, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 12, 2018
Development of a Validated Interferon Score Using NanoString TechnologyHanna Kim, Adriana A de Jesus, Stephen R Brooks, et al.
Ebiomedicine|July 3, 2015
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor BaricitinibAli Jabbari, Zhenpeng Dai, Luzhou Xing, et al.
Pediatric Radiology|June 25, 2026
Pediatric SARS-CoV-2 long term outcomes study: chest radiographic and computed tomography findings at baselineJonathan Zember, Evrim B Turkbey, Eric Chu, et al.
JCI Insight|August 18, 2017
Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonistMegha Garg, Adriana A de Jesus, Dawn Chapelle, et al.
Journal of Clinical Immunology|May 16, 2017
Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RNLeonardo O Mendonca, Louise Malle, Frank X Donovan, et al.
Annals of the Rheumatic Diseases|April 23, 2024
Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAASKader Cetin Gedik, Ana M Ortega-Villa, Grace Materne, et al.
Pageof 3